1Harris AW, Bodrug SE, Warnce BJ,et al. Cyclin D1 as the putative bel Ⅰ oncogene[J]. Curr Top Microbiol Immunol,1995,194:347-350.
2Grana X, Reddy EP. Cell cycle control in mammalian cells:role of cyclins, cyclin dependent kinases(CKIs), growth suppressor genes and cyclin dependent kinase inhibitors[J].Oncogene,1995,11:211-217.
3Marx J. How cells cycle towards cancer[J]. Science,1994,263(1):319-321.
4Lukas J, Bartkova J, Rohde M, et al. Cyclin D1 is dispensable for G1 control in retinoblastoma rene-deficient cells independently of CDK4 activity[J]. Mol Cell Biol,1995,15(5):2600-2611.
5Nurse P. The Josef Steiner Lecture: CDKs and cell-cycle control in fission yeast:relevance to other eukaryotes and cancer[J]. Int J Cancer,1997,71(5):707-708.
6Ohtsubo M, Theodoras AM, Schumacher J, et al. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition[J]. Mol Cell Biol,1995,15(5):2612-2625.
7Serrano M, Hannon GJ, Beach DA. A new regulatory modified in cell-cycle control causing specific inhibition of cyclin D/CDK4[J]. Nature,1993,366:704.
8Worsley SD, Jennings BA, Khalil KH, et al. Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression[J]. J Clin Pathol: Mol Pathol,1996,49:46-50.
9Schuuring E, Bristol G, Rosner E, et al. Amplification of genes within the chromosome llq13 region is indicative of poor prognosis in patients with operable breast cancer[J]. Cancer Res,1992,52(19):5229-5232.
10Wu K, Wang C, D'Amico M, et al. Flavopirdol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways[J]. Mol Cancer Ther,2002(9):695-706.
